These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4386877)

  • 1. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.
    Hansen JM; Kristensen M; Skovsted L
    Epilepsia; 1968 Mar; 9(1):17-22. PubMed ID: 4386877
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Inhibition of phenytoin metabolism by sulthiame.
    Houghton GW; Richens A
    Br J Pharmacol; 1973 Sep; 49(1):157P-158P. PubMed ID: 4150763
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy.
    Olesen OV; Jensen ON
    Dan Med Bull; 1969 May; 16(5):154-8. PubMed ID: 4392189
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sulthiame on blood and brain levels of diphenylhydantoin in the rat.
    Morselli PL; Rizzo M; Garattini S
    Biochem Pharmacol; 1970 May; 19(5):1846-7. PubMed ID: 4398022
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of phenytoin metabolism by other drugs used in epilepsy.
    Houghton GW; Richens A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):210-6. PubMed ID: 240782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of anticonvulsants.
    Eadie MJ; Tyrer JH
    Aust N Z J Med; 1973 Jun; 3(3):290-303. PubMed ID: 4147172
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of phenytoin in serum in the presence of barbiturates, sulthiame and ethosuximid by thin-layer chromatography.
    Vedsö S; Rud C; Place JF
    Scand J Clin Lab Invest; 1969 Apr; 23(2):175-80. PubMed ID: 4190278
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between anticonvulsants.
    Lander CM; Eadie MJ; Tyrer JH
    Proc Aust Assoc Neurol; 1975; 12():111-6. PubMed ID: 2912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with sulthiame (Ospolot).
    Liu MC
    Br J Psychiatry; 1966 Jun; 112(487):621-8. PubMed ID: 4381485
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroencephalographic investigations during evaluation of the antiepileptic agent sulthiame.
    Wilkus RJ; Green JR
    Epilepsia; 1974 Mar; 15(1):13-25. PubMed ID: 4151052
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenytoin intoxication induced by sulthiame in epileptic patients.
    Houghton GW; Richens A
    J Neurol Neurosurg Psychiatry; 1974 Mar; 37(3):275-81. PubMed ID: 4151416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylhydantoin substrate induced difference spectra: inhibition by other anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):31-43. PubMed ID: 6102406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of sulthiame ("Ospolot") in the epileptic child with the hyperkinetic syndrome.
    Kneebone GM
    Med J Aust; 1968 Dec; 2(24):1096-7. PubMed ID: 4387588
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and EEG study of Sulthiame (Elisal-Ospolot) in different forms of epilepsy and in petit mal].
    Gayral L; Candebat L; Fourny L
    Encephale; 1965; 54(5):446-57. PubMed ID: 4379392
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of voltage-operated sodium currents by the anticonvulsant drug sulthiame.
    Madeja M; Wolf C; Speckmann EJ
    Brain Res; 2001 May; 900(1):88-94. PubMed ID: 11325350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulthiame: evaluation as an anticonvulsant.
    Green JR; Troupin AS; Halperm LM; Friel P; Kanarek P
    Epilepsia; 1974 Sep; 15(3):329-49. PubMed ID: 4153094
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychological correlates of anticonvulsants and epileptiform discharges in adult epileptics.
    Dodrill CB; Wilkus RJ
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):259-67. PubMed ID: 35335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE USE OF OSPOLOT IN THE TREATMENT OF EPILEPSY.
    GORDON N
    Epilepsia; 1964 Mar; 5():68-73. PubMed ID: 14155207
    [No Abstract]   [Full Text] [Related]  

  • 19. A comprehensive scheme for the evaluation of anticonvulsant concentrations in blood using thin-layer chromatography.
    Gardner-Thorpe C; Parsonage MJ; Toothill C
    Clin Chim Acta; 1971 Nov; 35(1):39-47. PubMed ID: 4399557
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism in vitro of 5,5-diphenylhydantoin.
    Gabler WL; Hubbard GL
    Biochem Pharmacol; 1972 Nov; 21(22):3071-3. PubMed ID: 4405453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.